Cargando…
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
Glioblastoma is the most aggressive brain tumor with a median survival ranging from 6.2 to 16.7 months. The complex interactions between the tumor and the cells of tumor microenvironment leads to tumor evolution which ultimately results in treatment failure. Immunotherapy has shown great potential i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790087/ https://www.ncbi.nlm.nih.gov/pubmed/35096619 http://dx.doi.org/10.3389/fonc.2021.812916 |